SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001250853-17-000069
Filing Date
2017-08-08
Accepted
2017-08-08 14:29:13
Documents
1
Period of Report
2017-08-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2381
  Complete submission text file 0001250853-17-000069.txt   3788
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Issuer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 110 W. GEORGE BURNS ROAD SUITE D-4018 LOS ANGELES CA 90048
Business Address
EDDLEMAN ROY T (Reporting) CIK: 0001270264 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-14656 | Film No.: 171014283